156 related articles for article (PubMed ID: 34314309)
1. COVID-19 Vaccine Reactions in Dermatology: "Filling" in the Gaps.
Rice SM; Ferree SD; Kourosh AS
Cutis; 2021 Jun; 107(6):288-290. PubMed ID: 34314309
[No Abstract] [Full Text] [Related]
2. Delayed Localized Hypersensitivity Reactions to the Moderna COVID-19 Vaccine: A Case Series.
Johnston MS; Galan A; Watsky KL; Little AJ
JAMA Dermatol; 2021 Jun; 157(6):716-720. PubMed ID: 33978670
[TBL] [Abstract][Full Text] [Related]
3. Coronavirus Vaccination Adverse Reactions and the Role of the Dermatologist.
Pulsipher KJ; Presley CL; Waller JD; Szeto MD; Laughter MR; Dellavalle RP
J Drugs Dermatol; 2021 Mar; 20(3):351-352. PubMed ID: 33683080
[No Abstract] [Full Text] [Related]
4. Incidence of Cutaneous Reactions After Messenger RNA COVID-19 Vaccines.
Robinson LB; Fu X; Hashimoto D; Wickner P; Shenoy ES; Landman AB; Blumenthal KG
JAMA Dermatol; 2021 Aug; 157(8):1000-1002. PubMed ID: 34160555
[TBL] [Abstract][Full Text] [Related]
5. Morbilliform rash after administration of Pfizer-BioNTech COVID-19 mRNA vaccine.
Jedlowski PM; Jedlowski MF
Dermatol Online J; 2021 Jan; 27(1):. PubMed ID: 33560802
[No Abstract] [Full Text] [Related]
6. COVID-19 Vaccines and the Skin: The Landscape of Cutaneous Vaccine Reactions Worldwide.
Sun Q; Fathy R; McMahon DE; Freeman EE
Dermatol Clin; 2021 Oct; 39(4):653-673. PubMed ID: 34556254
[TBL] [Abstract][Full Text] [Related]
7. COVID Arm After Moderna Booster in Healthcare Worker: A Case Report.
Saifuddin A; Koesnoe S; Kurniati N; Sirait S; Arisanty R; Yunihastuti E
Acta Med Indones; 2021 Jul; 53(3):326-330. PubMed ID: 34611073
[TBL] [Abstract][Full Text] [Related]
8. Allergic and cutaneous reactions following inactivated SARS-CoV-2 vaccine (CoronaVac
Durmaz K; Aykut Temiz S; Metin Z; Dursun R; Abdelmaksoud A
Clin Exp Dermatol; 2022 Jan; 47(1):171-173. PubMed ID: 34415637
[No Abstract] [Full Text] [Related]
9. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines and Cutaneous Adverse Reactions: A Review.
Alpalhão M; Maia-Silva J; Filipe P
Dermatitis; 2021 May-Jun 01; 32(3):133-139. PubMed ID: 33851937
[TBL] [Abstract][Full Text] [Related]
10. Adverse cutaneous and mucous reactions from anti SARS-CoV-2 vaccines: recommendations from the Italian Society of Dermatology (SIDeMaST).
Stingeni L; Bianchi L; Zalaudek I; Pigatto PD; Peris K; Patruno C; Fabbrocini G; Micali G; Napolitano M; Tramontana M; Hansel K;
Ital J Dermatol Venerol; 2021 Apr; 156(2):115-117. PubMed ID: 33960747
[No Abstract] [Full Text] [Related]
11. Severe injection site reaction ensuing the first dose of mRNA COVID-19 vaccine.
Pierobon E; Sechi A; Germi L; Pezzolo E; Trevisan G; Feliciani C; Naldi L
Ital J Dermatol Venerol; 2022 Jun; 157(3):281-282. PubMed ID: 35373779
[No Abstract] [Full Text] [Related]
12. Ulcerative injection site reaction after third COVID-19 vaccine dose with mRNA-1273.
Barei F; Marletta DA; Marti-Marti I; Maronese CA; Genovese G; Marzano AV
Dermatol Ther; 2022 Aug; 35(8):e15631. PubMed ID: 35678474
[No Abstract] [Full Text] [Related]
13. Symmetrical drug-related intertriginous and flexural exanthema-like eruption after COVID-19 vaccine.
Lahouel I; Ben Salah N; Ben Fadhel N; Chahed F; Ouni N; Belhadjali H; Aouam K; Zili J
J Eur Acad Dermatol Venereol; 2022 Aug; 36(8):e597-e599. PubMed ID: 35344627
[No Abstract] [Full Text] [Related]
14. Mucocutaneous lichenoid eruptions following COVID-19 vaccination: A keen observation.
Arora A; Mohta A; Ghiya BC; Soni P; Jangir VK; Mehta RD
J Cosmet Dermatol; 2022 Sep; 21(9):3689-3691. PubMed ID: 35778897
[No Abstract] [Full Text] [Related]
15. Early atypical injection-site reactions to COVID-19 vaccine: a case series.
Vaccaro M; Bertino L; Squeri R; Genovese C; Isola S; Spatari G; Spina E; Cutroneo P
J Eur Acad Dermatol Venereol; 2022 Jan; 36(1):e24-e26. PubMed ID: 34547113
[No Abstract] [Full Text] [Related]
16. Recurrent injection-site reactions after incorrect subcutaneous administration of a COVID-19 vaccine.
Gyldenløve M; Skov L; Hansen CB; Garred P
J Eur Acad Dermatol Venereol; 2021 Sep; 35(9):e545-e546. PubMed ID: 33982318
[No Abstract] [Full Text] [Related]
17. Post-licensure safety surveillance of zoster vaccine live (Zostavax®) in the United States, Vaccine Adverse Event Reporting System (VAERS), 2006-2015.
Miller ER; Lewis P; Shimabukuro TT; Su J; Moro P; Woo EJ; Jankosky C; Cano M
Hum Vaccin Immunother; 2018; 14(8):1963-1969. PubMed ID: 29580194
[TBL] [Abstract][Full Text] [Related]
18. Skin reactions to COVID-19 vaccines: An American Academy of Dermatology/International League of Dermatological Societies registry update on reaction location and COVID vaccine type.
Freeman EE; Sun Q; McMahon DE; Singh R; Fathy R; Tyagi A; Blumenthal K; Hruza GJ; French LE; Fox LP
J Am Acad Dermatol; 2022 Apr; 86(4):e165-e167. PubMed ID: 34800601
[No Abstract] [Full Text] [Related]
19. Inadvertent subcutaneous injection of COVID-19 vaccine.
Ng JY
Postgrad Med J; 2021 Jun; 97(1148):400. PubMed ID: 33589486
[No Abstract] [Full Text] [Related]
20. How to Investigate a Serious Adverse Event Reported During a Clinical Trial for a COVID-19 Vaccine.
Shakir S; Lane S; Davies M
Drug Saf; 2021 Jan; 44(1):1-5. PubMed ID: 33219926
[No Abstract] [Full Text] [Related]
[Next] [New Search]
